HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paget's disease of bone: clinical features and treatment.

Abstract
Paget's disease of bone is often discovered incidentally, but can have extensive metabolic and local mechanical complications. Treatment is not required for all patients and should only be undertaken for certain indications, and with a clear understanding of the three types of drugs available. Bone pain unmanageable with analgesics and pathologic fractures are the most common indications, while neurologic symptoms, hypercalcemia and congestive heart failure are less frequent ones. Calcitonin or mithramycin is used for the more urgent indications, and calcitonin or the diphosphonate, etidronate sodium (EHDP), for the more chronic ones. The drugs are generally efficacious and well tolerated.
AuthorsA J Zajac, P E Phillips
JournalClinical and experimental rheumatology (Clin Exp Rheumatol) 1985 Jan-Mar Vol. 3 Issue 1 Pg. 75-88 ISSN: 0392-856X [Print] Italy
PMID3156705 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Diphosphonates
  • Uric Acid
  • Calcitonin
  • Plicamycin
  • Calcium
Topics
  • Bone Neoplasms (complications)
  • Calcitonin (therapeutic use)
  • Calcium (blood)
  • Cardiovascular Diseases (complications)
  • Diphosphonates (therapeutic use)
  • Gout (complications)
  • Humans
  • Osteitis Deformans (diagnosis, diagnostic imaging, pathology, therapy)
  • Osteosarcoma (complications)
  • Plicamycin (therapeutic use)
  • Radiography
  • Uric Acid (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: